<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Assist Reprod Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Assist. Reprod. Genet</journal-id>
<journal-title-group>
<journal-title>Journal of Assisted Reproduction and Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1058-0468</issn>
<issn pub-type="epub">1573-7330</issn>
<publisher>
<publisher-name>Springer US</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29926373</article-id>
<article-id pub-id-type="pmc">6086796</article-id>
<article-id pub-id-type="publisher-id">1237</article-id>
<article-id pub-id-type="doi">10.1007/s10815-018-1237-y</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Use of human-derived stem cells to create a novel, in vitro model designed to explore <italic>FMR1</italic> CGG repeat instability amongst female premutation carriers</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gustin</surname>
<given-names>Stephanie L. F.</given-names>
</name>
<address>
<email>Fisher.stephanieL@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Guangwen</given-names>
</name>
<address>
<email>Gavin.wang@stanford.edu</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>Valerie M.</given-names>
</name>
<address>
<email>vlbaker@stanford.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Latham</surname>
<given-names>Gary</given-names>
</name>
<address>
<email>glatham@asuragen.com</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sebastiano</surname>
<given-names>Vittorio</given-names>
</name>
<address>
<email>vsebast@stanford.edu</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution>Department Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, </institution><institution>Stanford University School of Medicine, </institution></institution-wrap>Stanford, CA 94305 USA </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution>Department of Genetics, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA 94305 USA </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.422997.3</institution-id><institution>Research and Technology Development, </institution><institution>Asuragen, Inc., </institution></institution-wrap>Austin, TX 78744 USA </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368956</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution>Institute for Stem Cell Biology &amp;Regenerative Medicine, Stanford University School of Medicine, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA 94305 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>20</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2018</year>
</pub-date>
<volume>35</volume>
<issue>8</issue>
<fpage>1443</fpage>
<lpage>1455</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© Springer Science+Business Media, LLC, part of Springer Nature 2018</copyright-statement>
</permissions>
<abstract id="Abs1">
<sec>
<title>Objective</title>
<p id="Par1">Create a model, using reprogrammed cells, to provide a platform to identify the mechanisms of CGG repeat instability amongst female fragile X mental retardation 1 gene (FMR1) premutation (PM) carriers.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">Female PM carriers (with and without POI) and healthy controls were enrolled from June 2013 to April 2014. Patient-derived fibroblasts (FB) were reprogrammed to induced pluripotent stem cells (iPSC) using viral vectors, encoding KLF4, OCT4, SOX2, and MYC. FMR1 CGG repeat-primed PCR was used to assess the triplet repeat structure of the FMR1 gene. FMR1 promoter methylation (%) was determined using FMR1 methylation PCR (mPCR). Quantification of FMR1 transcripts by RT-qPCR was used to evaluate the effect of reprogramming on gene transcription, as well as to correlate patient phenotype with FMR1 expression. Production of FMR1 protein (FMRP) was determined using a liquid bead array-based immunoassay.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">Upon induction to pluripotency, all control clones exhibited maintenance of progenitor cell CGG repeat number, whereas 10 of 12 clones derived from PM carriers maintained their input CGG repeat number, one of which expanded and one contracted. As compared to parent FB, iPSC clones exhibited a skewed methylation pattern; however, downstream transcription and translation appeared unaffected. Further, the PM carriers, regardless of phenotype, exhibited similar FMR1 transcription and translation to the controls.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">This is the first study to establish a stem cell model aimed to understand FMR1 CGG repeat instability amongst female PM carriers. Our preliminary data indicate that CGG repeat number, transcription, and translation are conserved upon induction to pluripotency.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1007/s10815-018-1237-y) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>iPSC</kwd>
<kwd>Stem cell</kwd>
<kwd>FMR1</kwd>
<kwd>Premutation</kwd>
<kwd>Primary ovarian insufficiency</kwd>
<kwd>CGG repeat</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>U54HD068158</award-id>
<principal-award-recipient>
<name>
<surname>Baker</surname>
<given-names>Valerie M.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Science+Business Media, LLC, part of Springer Nature 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>